← FDA Drug Approvals (Drugs@FDA)

HEPARIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-02-06

Drug application

FDA Application #

ANDA205323

Application type

Abbreviated New Drug Application (Generic)

Brand name

HEPARIN SODIUM

Generic name

HEPARIN SODIUM

Active ingredients

HEPARIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Gland Pharma Limited

First approval

2017-02-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown